Association between Helicobacter pylori infection and pancreatic cancer development: a meta-analysis
- PMID: 24086571
- PMCID: PMC3784458
- DOI: 10.1371/journal.pone.0075559
Association between Helicobacter pylori infection and pancreatic cancer development: a meta-analysis
Abstract
Background: Pancreatic cancer is one of the most troublesome malignancies with dismal prognosis. H. pylori has been recognized as a type I carcinogen. Several studies have evaluated the association between H. pylori infection and pancreatic cancer development, however, the conclusions are inconsistent.
Methods: Literature search was carried out in PubMed, EMBASE, Cochrane Library and CNKI databases to identify eligible researches. We performed overall meta-analysis of all studies included and subgroup analysis based on regional distribution. Quality of the studies (assessed by Newcastle-Ottawa quality assessment scale for case-control studies) and CagA+ strains of H. pylori were taken into consideration, and we conducted additional analyses including high-quality researches and those concerning CagA+ H. pylori respectively.
Results: 9 studies involving 3033 subjects (1083 pancreatic cancer cases, 1950 controls) were included. Summary OR and 95%CI of the overall meta-analysis of all included studies were 1.47 and 1.22-1.77, pooled data of the 4 high-quality studies were OR 1.28, 95%CI 1.01-1.63. OR of the 5 studies examined CagA+ strains was 1.42, corresponding 95%CI was 0.79 to 2.57. Summary estimates of subgroup analysis based on regional distribution are as follows, Europe group: OR 1.56, 95%CI 1.15-2.10; East Asia group: OR 2.01, 95%CI 1.33-3.02; North America group: OR 1.17, 95%CI 0.87-1.58. There was not obvious heterogeneity across the 9 studies. No publication bias was detected.
Conclusion: H. pylori infection is significantly, albeit weakly, associated with pancreatic cancer development. The association is prominent in Europe and East Asia, but not in North America. CagA+ H. pylori strains appear not to be associated with pancreatic cancer. However, more studies, especially prospective studies, are needed to validate our results.
Conflict of interest statement
Figures
References
-
- Hidalgo M (2010) Pancreatic cancer. N Engl J Med 362: 1605-1617. doi:10.1056/NEJMra0901557. PubMed: 20427809. - DOI - PubMed
-
- Hassan MM, Bondy ML, Wolff RA, Abbruzzese JL, Vauthey JN et al. (2007) Risk factors for pancreatic cancer: case-control study. Am J Gastroenterol 102: 2696-2707. doi:10.1111/j.1572-0241.2007.01510.x. PubMed: 17764494. - DOI - PMC - PubMed
-
- Lowenfels AB, Maisonneuve P (2002) Epidemiologic and etiologic factors of pancreatic cancer. Hematol Oncol Clin North Am 16: 1-16. doi:10.1016/S0889-8588(01)00003-X. PubMed: 12063821. - DOI - PubMed
-
- Raimondi S, Maisonneuve P, Lowenfels AB (2009) Epidemiology of pancreatic cancer: an overview. Nat Rev Gastroenterol Hepatol 6: 699-708. doi:10.1038/nrgastro.2009.177. - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
